The largest database of trusted experimental protocols

Mlo y4

Manufactured by MSD
Sourced in Japan

The MLO-Y4 is a laboratory equipment product. It is designed for use in scientific research and analysis. The core function of the MLO-Y4 is to perform a specific task or operation within a laboratory setting. No further details on the intended use or capabilities of the product can be provided in an unbiased and factual manner.

Automatically generated - may contain errors

2 protocols using mlo y4

1

Effects of Dexamethasone and Hypoxia on Osteocyte and Mesenchymal Stem Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
An established murine osteocyte cell line (MLO-Y4) (Kerafast, Boston, MA) was maintained as a subconfluent monolayer culture in the MEM alpha medium (Gibco, Tokyo, Japan) supplemented with 10% fetal calf serum 10 (link). Mouse MSC derived from the bone marrow (Cyagen, Silicon Valley, CA) was maintained in the stem cell growth medium (Cyagen). Both cell lines were cultured at 37°C under 20% O2 and 5% CO2. At the culture reached 80% confluency while being cultured at 37°C under 20% O2 and 5% CO2, both cell lines, MLO-Y4 and MSC, were treated under three different conditions for 24 hours: exposed to Dexamethasone (Dex, MSD, Tokyo, Japan) at the concentration of 0.4 ng/ml (Dex group); hypoxia at a 1% oxygen concentration (Hypoxia group) or both (Dex/Hypoxia group). As a control (C group), both cell lines were cultured under 20% oxygen in the culture medium without Dexamethasone. After the exposure, the numbers of viable and nonviable cells determined using 0.25% trypan blue dye exclusion method were counted with Countess 2 FL (Thermo Fisher Scientific, Waltham, MA), and survival rates were calculated.
+ Open protocol
+ Expand
2

Murine Osteocytes Under Hypoxia and Dexamethasone

Check if the same lab product or an alternative is used in the 5 most similar protocols
An established murine osteocytic cell line (MLO-Y4) (Kerafast, Boston, MA, USA) was maintained as a subconfluent monolayer culture in the alpha MEM medium (Gibco, Tokyo, Japan) supplemented with 10% fetal calf serum. When the culture reached 70% confluency being cultured at 37 °C under 20% O2 and 5% CO2, MLO-Y4 were treated with 1 µM Dexamethasone (Dex, MSD, Tokyo, Japan) in 1% O2 (hypoxia) for 24 h (Dex+/hypoxia+ group). A quantity of 0.8 µM taurine was added to the medium of Dex+/hypoxia+ group exposed to taurine-free medium (Dex+/hypoxia+/taurine+ group). As a control group, cells were cultured under 20% O2 in the culture medium without either Dex or taurine (Dex-/hypoxia− group). Three independent experiments each were carried out.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!